(VIANEWS) – Provident Financial Services (PFS), Bank First Corporation (BFC), Axcelis Technologies (ACLS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Provident Financial Services (PFS)
39% sales growth and 10.56% return on equity
Provident Financial Services, Inc. operates as the holding company for Provident Bank that provides various banking services to individuals, families, and businesses in the United States. The company's deposit products include savings, checking, interest-bearing checking, money market deposit, and certificate of deposit accounts, as well as IRA products. Its loan portfolio comprises commercial real estate loans that are secured by properties, such as multi-family apartment buildings, office buildings, and retail and industrial properties; commercial business loans; fixed-rate and adjustable-rate mortgage loans collateralized by one- to four-family residential real estate properties; commercial construction loans; and consumer loans consisting of home equity loans, home equity lines of credit, marine loans, personal loans, and auto and recreational vehicle loans. The company also offers cash management, remote deposit capture, payroll origination, escrow account management, and online and mobile banking services; and business credit cards. In addition, it provides wealth management services comprising investment management, trust and estate administration, financial planning, tax compliance and planning, and private banking. Further, the company sells insurance and investment products, including annuities; operates as a real estate investment trust for acquiring mortgage loans and other real estate related assets; and manages and sells real estate properties acquired through foreclosure. As of December 31, 2019, it operated 83 full-service branch offices in northern and central New Jersey, as well as in Pennsylvania. The company was founded in 1839 and is headquartered in Jersey City, New Jersey.
Earnings Per Share
As for profitability, Provident Financial Services has a trailing twelve months EPS of $2.31.
PE Ratio
Provident Financial Services has a trailing twelve months price to earnings ratio of 7.46. Meaning, the purchaser of the share is investing $7.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.
Sales Growth
Provident Financial Services’s sales growth is 14.7% for the present quarter and 39% for the next.
Volume
Today’s last reported volume for Provident Financial Services is 295985 which is 42.16% below its average volume of 511750.
2. Bank First Corporation (BFC)
20.4% sales growth and 10.38% return on equity
Bank First Corporation operates as a holding company for Bank First N.A. that provides consumer and commercial financial services to businesses, professionals, consumers, associations, individuals, and governmental authorities in Wisconsin. The company offers checking, savings, money market, cash management, retirement, and health savings accounts; other time deposits; certificates of deposit; and residential mortgage products. It also provides credit cards; ATM processing; insurance; data processing and other information technology; investment and safekeeping; treasury management; and online, telephone, and mobile banking services. The company's loan products include real estate loans, including commercial real estate, residential mortgage, and home equity loans; commercial and industrial loans for working capital, accounts receivable, inventory financing, and other business purposes; construction and development loans; residential 1-4 family loans; and consumer loans for personal and household purposes, including secured and unsecured installment loans, and revolving lines of credit. The company was formerly known as Bank First National Corporation and changed its name to Bank First Corporation in June 2019. Bank First Corporation was founded in 1894 and is headquartered in Manitowoc, Wisconsin.
Earnings Per Share
As for profitability, Bank First Corporation has a trailing twelve months EPS of $5.32.
PE Ratio
Bank First Corporation has a trailing twelve months price to earnings ratio of 15.8. Meaning, the purchaser of the share is investing $15.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.38%.
Previous days news about Bank First Corporation(BFC)
- Bank first corporation (bfc) Q2 earnings surpass estimates. According to Zacks on Tuesday, 18 July, "While Bank First Corporation has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
3. Axcelis Technologies (ACLS)
16.2% sales growth and 30% return on equity
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
Earnings Per Share
As for profitability, Axcelis Technologies has a trailing twelve months EPS of $5.94.
PE Ratio
Axcelis Technologies has a trailing twelve months price to earnings ratio of 30.28. Meaning, the purchaser of the share is investing $30.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30%.
Yearly Top and Bottom Value
Axcelis Technologies’s stock is valued at $179.85 at 20:22 EST, under its 52-week high of $186.68 and way above its 52-week low of $49.78.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 10.6% and 38.8%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Axcelis Technologies’s EBITDA is 73.26.
Sales Growth
Axcelis Technologies’s sales growth is 16.1% for the present quarter and 16.2% for the next.
4. Boston Scientific (BSX)
8.4% sales growth and 5.18% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Earnings Per Share
As for profitability, Boston Scientific has a trailing twelve months EPS of $0.59.
PE Ratio
Boston Scientific has a trailing twelve months price to earnings ratio of 90.75. Meaning, the purchaser of the share is investing $90.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.18%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Boston Scientific’s EBITDA is 112.74.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 11.4% and 11.6%, respectively.
Previous days news about Boston Scientific(BSX)
- Will Boston Scientific (bsx) beat Q2 earnings estimates?. According to Zacks on Thursday, 20 July, "In terms of innovation, recently, Boston Scientific launched Trusteer, its new steerable sheath, and also highlighted the next-generation FLX device, WATCHMAN FLX PRO, at the TCT investor event. ", "Boston Scientific Corporation price-eps-surprise | Boston Scientific Corporation Quote"
- According to Zacks on Wednesday, 19 July, "Some better-ranked stocks in the broader medical space are Becton, Dickinson and Company (BDX Quick QuoteBDX – Free Report) , popularly known as BD, HealthEquity, Inc. (HQY Quick QuoteHQY – Free Report) and Boston Scientific Corporation (BSX Quick QuoteBSX – Free Report) ."
- According to Zacks on Tuesday, 18 July, "A few other top-ranked stocks in the broader medical space are Becton, Dickinson and Company (BDX Quick QuoteBDX – Free Report) , popularly known as BD, HealthEquity, Inc. (HQY Quick QuoteHQY – Free Report) and Boston Scientific Corporation (BSX Quick QuoteBSX – Free Report) ."
- According to Zacks on Tuesday, 18 July, "A few other top-ranked stocks in the broader medical space are Abbott Laboratories (ABT Quick QuoteABT – Free Report) , HealthEquity, Inc. (HQY Quick QuoteHQY – Free Report) and Boston Scientific Corporation (BSX Quick QuoteBSX – Free Report) ."
